Anticancer peptide CIGB-300 binds to nucleophosmin/B23, impairs its CK2-mediated phosphorylation, and leads to apoptosis through its nucleolar disassembly activity.
about
NPM1/B23: A Multifunctional Chaperone in Ribosome Biogenesis and Chromatin RemodelingNucleophosmin: from structure and function to disease developmentMolecules that target nucleophosmin for cancer treatment: an updateProtein kinase CK2 and human malignant tumorsOptimizing CIGB-300 intralesional delivery in locally advanced cervical cancer.Synergistic interactions of the anti-casein kinase 2 CIGB-300 peptide and chemotherapeutic agents in lung and cervical preclinical cancer models.Elucidation of motifs in ribosomal protein S9 that mediate its nucleolar localization and binding to NPM1/nucleophosminBiophysical Characterization of Nucleophosmin Interactions with Human Immunodeficiency Virus Rev and Herpes Simplex Virus US11.Altered nucleophosmin transport in acute myeloid leukaemia with mutated NPM1: molecular basis and clinical implications.Casein kinase: the triple meaning of a misnomer.The synthetic peptide CIGB-300 modulates CK2-dependent signaling pathways affecting the survival and chemoresistance of non-small cell lung cancer cell linesPharmacologic inhibition of the CK2-mediated phosphorylation of B23/NPM in cancer cells selectively modulates genes related to protein synthesis, energetic metabolism, and ribosomal biogenesis.Sensitivity of tumor cells towards CIGB-300 anticancer peptide relies on its nucleolar localization.Identification and characterization of a bactericidal and proapoptotic peptide from Cycas revoluta seeds with DNA binding properties.Immunopharmacology 2011: an updated report of clinical achievements and perspectives.
P2860
Q21296810-0747A540-DBD7-4275-A70C-C923B83995C9Q26739704-67E52E8A-3BA5-40B4-8BC1-ABD3EAE2AEBFQ26750653-41214AC3-E832-43E9-8A5F-D68BDFBF48E5Q27026335-083D0C87-6D44-4AB2-81D7-528D81E138EEQ27332192-E43C94A2-5768-49CA-8B10-6EA093513BF2Q34265716-BACF12CE-ACF1-48DC-86F2-36F0321490BBQ34533969-467FD86A-9318-4500-B317-21FB70D1F59CQ35857057-DB6B0171-AAA9-4C8B-B629-FF0E84A094B9Q37514846-F8F9AEDD-11C6-46B3-A1DB-5895AD1D3FC3Q38211598-1D3543CF-486C-446C-9217-7F2450583E8AQ38709045-DFB6CB9A-9C0E-4F1A-9081-B967E9CC7A7AQ38895608-71D82A29-85B7-4C11-93A7-5F3A57BDCFB0Q39381625-EA4236B3-A1BD-412C-B385-4FEA2E81F3B8Q39481226-1FD9EBC8-F618-48A3-B37C-04A49ECFF60BQ48027434-2997D002-E726-449E-A861-492971DC9B75
P2860
Anticancer peptide CIGB-300 binds to nucleophosmin/B23, impairs its CK2-mediated phosphorylation, and leads to apoptosis through its nucleolar disassembly activity.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
2009年论文
@zh
2009年论文
@zh-cn
name
Anticancer peptide CIGB-300 bi ...... ucleolar disassembly activity.
@en
Anticancer peptide CIGB-300 bi ...... ucleolar disassembly activity.
@nl
type
label
Anticancer peptide CIGB-300 bi ...... ucleolar disassembly activity.
@en
Anticancer peptide CIGB-300 bi ...... ucleolar disassembly activity.
@nl
prefLabel
Anticancer peptide CIGB-300 bi ...... ucleolar disassembly activity.
@en
Anticancer peptide CIGB-300 bi ...... ucleolar disassembly activity.
@nl
P2093
P1476
Anticancer peptide CIGB-300 bi ...... nucleolar disassembly activity
@en
P2093
Arielis Rodriguez
Boris E Acevedo
Fernando Benavent
Hernán G Farina
Jeovanis Gil
Lila Castellanos
Roberto E Gómez
Silvio E Perea
Yasser Perera
P304
P356
10.1158/1535-7163.MCT-08-1056
P577
2009-05-05T00:00:00Z